| Wells F
The impact of clinical trials legislation on clinical pharmacology: problems and solutions. [Comment, Letter]
Br J Clin Pharmacol 2009 Nov; 68(5):773-4; author reply 775-7; discussion 778.
Full Citation | Publisher Full Text | Find Related Articles | | de Beaumais TA, Fakhoury M, Pigneur B, et al.
Characterization of a novel TPMT mutation associated with azathioprine-induced myelosuppression. [Letter]
Br J Clin Pharmacol 2009 Nov; 68(5):770-2.
Full Citation | Publisher Full Text | Find Related Articles | | Tesmoingt C, Lidove O, Reberga A, et al.
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies. [Journal Article]
Br J Clin Pharmacol 2009 Nov; 68(5):765-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wheeler BW, Metcalfe C, Gunnell D, et al.
Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):752-64.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jolly K, Gammage MD, Cheng KK, et al.
Sudden death in patients receiving drugs tending to prolong the QT interval. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):743-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Abdel-tawab AM, Bradley M, Ghazaly EA, et al.
Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):737-42.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Grosso A, Douglas I, Hingorani AD, et al.
Inhaled tiotropium bromide and risk of stroke. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):731-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | He X, Hesse LM, Hazarika S, et al.
Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. [Journal Article, Research Support, N.I.H., Extramural]
Br J Clin Pharmacol 2009 Nov; 68(5):721-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Grün B, Krautter S, Riedel KD, et al.
Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole. [Journal Article]
Br J Clin Pharmacol 2009 Nov; 68(5):712-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Barras MA, Duffull SB, Atherton JJ, et al.
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):700-11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
